Related Experiment Video
Updated: Jan 23, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Impact of Kidney Replacement Therapy During Extracorporeal Membrane Oxygenation Support in Terms of Mortality: A
Ranjit Sah1, Amita Paudel2, Sangam Shah3
1Department of Internal Medicine BMC South, BMC Health System Massachusetts USA.
Introduction:
Extracorporeal membrane oxygenation (ECMO) is a life-saving intervention for refractory cardiopulmonary failure. Despite advancements reducing complications, ECMO remains associated with acute kidney injury (AKI), often requiring kidney replacement therapy (KRT). Studies report up to 45% of ECMO patients needing KRT, significantly increasing mortality. A prior meta-analysis suggested a declining mortality trend in recent years.
Methodology:
Following PRISMA guidelines, PubMed, MEDLINE, EMBASE, and Cochrane Library were searched (2000-2024) for randomized and observational studies on adult ECMO patients requiring KRT. Data extraction covered study characteristics, patient demographics, ECMO type, KRT timing, and clinical outcomes. Quality was assessed using the Newcastle-Ottawa Scale. Statistical analyses were performed using RevMan 5.4.1 under a random-effects model, with mortality as the primary outcome.
Result:
A total of 24 studies (6347 patients) met the inclusion criteria, including 23 observational studies and one RCT. The mean age of ECMO + KRT patients was 51 years in observational studies and 61.2 years in the RCT, with cardiogenic shock as the most common ECMO indication. Meta-analysis showed a significantly higher mortality in ECMO + KRT patients (RR: 1.86, 95% CI: 1.63-2.12, p < 0.001), with infections and bleeding as key contributors. Subgroup analysis revealed no significant survival difference based on KRT timing, while Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was associated with worse outcomes than Veno-venous extracorporeal membrane oxygenation (VV-ECMO). The RCT reported 61.9% mortality at 30 days in ECMO + KRT patients.
Conclusion:
KRT during ECMO is associated with increased mortality, likely due to the severity of illness and complications like infections and bleeding. The optimal timing of KRT initiation remains unclear, and no significant survival benefit was found for early KRT. Further large-scale RCTs are needed to optimize management strategies.
More Related Videos
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Kidney Structure
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...